A multivariate analysis of total events, stratified by total patient follow‐up time post index date, demonstrated a statistically significant lower total event incidence (incidence rate ratio <1) for metformin + DPP‐4 inhibitor compared with metformin + SU for patients with ≥1 (borderline significant), 2 and 3 years follow‐up (Figure S5 in Appendix S1).
← all excerpts
Managing glycaemia in older people with type 2 diabetes: A retrospective, primary care-based cohort study, with economic assessment of patient outcomes.
1
—
—